Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
TWST Twist Bioscience Corp
- Stocks
- Healthcare
- NASDAQ: TWST
Price (delayed)
$38.47
Market cap
$2.3B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.25
Enterprise value
$2.19B
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of
Highlights
TWST's gross profit has surged by 53% year-on-year and by 10% since the previous quarter
TWST's revenue is up by 25% YoY and by 5% from the previous quarter
Twist Bioscience's debt has increased by 7% YoY but it has decreased by 2.4% from the previous quarter
Twist Bioscience's equity has decreased by 21% YoY and by 3.5% QoQ
TWST's quick ratio is down by 16% year-on-year and by 8% since the previous quarter
Key stats
What are the main financial stats of TWST
Market
Valuations
Earnings
Shares outstanding
59.92M
Market cap
$2.3B
Enterprise value
$2.19B
Price to earnings (P/E)
N/A
Price to book (P/B)
5.21
Price to sales (P/S)
6.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.3
Revenue
$347.68M
Gross profit
$162.37M
Operating income
-$201.17M
Net income
-$191.15M
EBIT
-$190.59M
EBITDA
-$162.41M
Free cash flow
-$65.49M
Per share
Balance sheet
Liquidity
EPS
-$3.25
EPS diluted
-$3.25
Free cash flow per share
-$1.1
Book value per share
$7.38
Revenue per share
$5.83
TBVPS
$8.31
Total assets
$595.62M
Total liabilities
$155.51M
Debt
$95.3M
Equity
$440.11M
Working capital
$263.47M
Debt to equity
0.22
Current ratio
4.51
Quick ratio
4.1
Net debt/EBITDA
0.71
Margins
Efficiency
Dividend
EBITDA margin
-46.7%
Gross margin
46.7%
Net margin
-55%
Operating margin
-57.9%
Return on assets
-31.1%
Return on equity
-41.1%
Return on invested capital
-61.8%
Return on capital employed
-36.6%
Return on sales
-54.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TWST stock price
How has the Twist Bioscience stock price performed over time
Intraday
-1.66%
1 week
0.79%
1 month
11.67%
1 year
-24.55%
YTD
-17.22%
QTD
4.57%
Financial performance
How have Twist Bioscience's revenue and profit performed over time
Revenue
$347.68M
Gross profit
$162.37M
Operating income
-$201.17M
Net income
-$191.15M
Gross margin
46.7%
Net margin
-55%
TWST's gross profit has surged by 53% year-on-year and by 10% since the previous quarter
TWST's revenue is up by 25% YoY and by 5% from the previous quarter
TWST's gross margin is up by 22% year-on-year and by 4.7% since the previous quarter
Twist Bioscience's operating margin has increased by 22% YoY and by 8% QoQ
Price vs fundamentals
How does TWST's price correlate with its fundamentals
Growth
What is Twist Bioscience's growth rate over time
Valuation
What is Twist Bioscience stock price valuation
P/E
N/A
P/B
5.21
P/S
6.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.3
TWST's EPS is up by 3.8% since the previous quarter and by 3.3% year-on-year
Twist Bioscience's equity has decreased by 21% YoY and by 3.5% QoQ
TWST's P/B is 9% below its last 4 quarters average of 5.7
TWST's P/S is 66% below its 5-year quarterly average of 19.6 and 20% below its last 4 quarters average of 8.3
TWST's revenue is up by 25% YoY and by 5% from the previous quarter
Efficiency
How efficient is Twist Bioscience business performance
The return on equity has declined by 30% year-on-year and by 3% since the previous quarter
The ROA has decreased by 22% YoY
TWST's return on sales is up by 20% year-on-year and by 8% since the previous quarter
Twist Bioscience's ROIC has decreased by 17% YoY
Dividends
What is TWST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TWST.
Financial health
How did Twist Bioscience financials performed over time
The current ratio has contracted by 18% YoY and by 9% from the previous quarter
TWST's quick ratio is down by 16% year-on-year and by 8% since the previous quarter
Twist Bioscience's debt is 78% less than its equity
Twist Bioscience's debt to equity has increased by 38% YoY and by 4.8% QoQ
Twist Bioscience's equity has decreased by 21% YoY and by 3.5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.